Cases | n | Male/Female | Disease duration [months] | Age at death [years] | PAR-2 [ng/ml] | T-tau [pg/ml] | P-tau [pg/ml] | Aβ [pg/ml] | 14-3-3 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
P | W | N | ||||||||||
CJD | 36 | 12/24 | 6.8 ± 8.3 [1–48] | 63.1 ± 8.3 [39–81] | 8.78 ± 6.40 [1.25–28.49] | 1111.47 ± 264.48 [195–1201] | 52.69 ± 30.86 [16–166] | 619.39 ± 297.34 [212–1407] | 21 | 7 | 8 | |
non-CJD | 23 | 15/8 | 24.1 ± 22.2 [2–84] | 71.0 ± 10.4 [53–90] | 9.31 ± 8.71 [1.22–41] | 632.43 ± 434.03 [65–1201] | 47.48 ± 28.38 [15–103] | 561.22 ± 421.20 [94–1672] | 4 | 3 | 16 | |
AD | 6 | 4/2 | 28.67 ± 29.87 [2–84] | 70 ± 10.66 [54–82] | 13.26 ± 14.62 [1.22–41] | 926.83 ± 366.99 [268–1201] | 53.83 ± 27.67 [29–102] | 401 ± 409.04 [94–1109] | 1 | 2 | 3 | |
FTLD-TDP | 11 | 7/4 | 17.2 ± 14.86 [3–46] | 70.8 ± 11.4 [53–90] | 8.15 ± 5.96 [1.73–21.79] | 558.27 ± 424.44 [134–1201] | 39.10 ± 24.35 [15–94] | 517.64 ± 241.35 [265–1065] | 2 | 0 | 9 | |
VD | 4 | 3/1 | 27.5 ± 31 [2–72] | 70.5 ± 7.1 [62–79] | 5.03 ± 1.61 [2.79–6.44] | 547 ± 521.99 [65–1201] | 52.25 ± 38.45 [20–103] | 945 ± 755.50 [186–1672] | 1 | 1 | 2 | |
PSP | 2 | 1/1 | 38 ± 2.83 [36–40] | 76.5 ± 17.68 [64–89] | 12.36 ± 6.05 [8.08–16.64] | 328 ± 239 [159–497] | 65 ± 42.43 [35–95] | 514 ± 55.15 [475–553] | 0 | 0 | 2 |